Literature DB >> 25407648

Importance of intestinal microenvironment in development of arthritis. A systematic review.

Anna Bazsó1, Péter Szodoray, Gábor Sütő, Yehuda Shoenfeld, Gyula Poór, Emese Kiss.   

Abstract

A strong connection between spondylarthropathies and inflammatory bowel diseases (IBD) is well established. About 10-15% of IBD are associated with different forms of spondylarthritis. Arthritis can be manifested as axial, peripheral form or both. The primary functions of the gastrointestinal tract are digestion and absorption of nutrients, electrocytes and maintenance of water homoeostasis. The anatomic and functional lesions could lead to the development of IBD based on molecular mimicry and bystander effects. The mechanism of the macromolecules is uptaken may affect intestinal and extraintestinal manifestation in genetically susceptible individuals by gut-associated lymphoid tissue, the interplay between innate and adaptive immunity and the neuroendocrine network.

Entities:  

Mesh:

Year:  2015        PMID: 25407648     DOI: 10.1007/s12026-014-8593-1

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  49 in total

1.  Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores.

Authors:  Hugues Lelouard; Mathieu Fallet; Béatrice de Bovis; Stéphane Méresse; Jean-Pierre Gorvel
Journal:  Gastroenterology       Date:  2011-12-08       Impact factor: 22.682

2.  Post intestinal bypass arthritis-dermatitis syndrome.

Authors:  N Del Val Del Amo; R Ibanez Bosch
Journal:  Clin Exp Rheumatol       Date:  2008 Mar-Apr       Impact factor: 4.473

3.  HLA-B51 subtypes in Turkish patients with Behçet's disease and their correlation with clinical manifestations.

Authors:  D D Demirseren; G G Ceylan; G Akoglu; S Emre; S Erten; A Arman; A Metin
Journal:  Genet Mol Res       Date:  2014-07-02

4.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; N Yu
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

Review 5.  The epidemiology and the pathogenesis of inflammatory bowel disease.

Authors:  K Karlinger; T Györke; E Makö; A Mester; Z Tarján
Journal:  Eur J Radiol       Date:  2000-09       Impact factor: 3.528

6.  CARD15/NOD2 analyses in spondylarthropathy.

Authors:  Corinne Miceli-Richard; Habib Zouali; Suzanne Lesage; Gilles Thomas; Jean-Pierre Hugot; Roula Said-Nahal; Maxime Breban
Journal:  Arthritis Rheum       Date:  2002-05

7.  Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies.

Authors:  Massimo-C Fantini; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

8.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

9.  Secretory IgA: Designed for Anti-Microbial Defense.

Authors:  Per Brandtzaeg
Journal:  Front Immunol       Date:  2013-08-06       Impact factor: 7.561

10.   Ileocecal patch -low rectal anastomosis in total colectomy: New idea for the prevention of fecal incontinence.

Authors:  Valiullah Mehrabi; Leily Mohajerzadeh; Alireza Mirshemirani; Ahmad Khaleghnejad Tabari; Azadeh Falahi; Shabnam Abtahi; Marjan Kafaei
Journal:  Caspian J Intern Med       Date:  2014
View more
  1 in total

1.  Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.

Authors:  Maja Skov Kragsnaes; Jens Kjeldsen; Hans Christian Horn; Heidi Lausten Munk; Finn Moeller Pedersen; Hanne Marie Holt; Jens Kristian Pedersen; Dorte Kinggaard Holm; Henning Glerup; Vibeke Andersen; Ulrich Fredberg; Karsten Kristiansen; Robin Christensen; Torkell Ellingsen
Journal:  BMJ Open       Date:  2018-04-27       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.